S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NYSEARCA:IHI

iShares U.S. Medical Devices ETF Stock Forecast, Price & News

$61.87
-0.39 (-0.63%)
(As of 12/3/2021 12:00 AM ET)
Add
Today's Range
$61.21
$62.89
50-Day Range
$61.58
$66.09
52-Week Range
$52.17
$67.29
Volume
1.39 million shs
Average Volume
1.09 million shs
Market Capitalization
$8.36 billion
P/E Ratio
N/A
Dividend Yield
0.81%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive IHI News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares U.S. Medical Devices ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer iShares
Fund NameiShares U.S. Medical Devices ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:IHI
Inception Date5/1/2006
Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkDow Jones US Select Medical Devices Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$8.37 billion
Average Daily Volume$1.10 million
Discount/Premium-0.04%

ETF Expenses

Management Fee0.41%
Other Expenses0.00%
Total Expenses0.41%
Fee Waiver0.00%
Net Expenses0.41%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market Maker

Geographic Exposure of IHI

Currency Exposure of IHI

Sector Exposure of IHI

Industry Exposure of IHI













iShares U.S. Medical Devices ETF (NYSEARCA:IHI) Frequently Asked Questions

How has iShares U.S. Medical Devices ETF's stock been impacted by Coronavirus (COVID-19)?

iShares U.S. Medical Devices ETF's stock was trading at $38.3983 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IHI shares have increased by 61.1% and is now trading at $61.87.
View which stocks have been most impacted by COVID-19
.

Is iShares U.S. Medical Devices ETF a good dividend stock?

iShares U.S. Medical Devices ETF pays an annual dividend of $0.51 per share and currently has a dividend yield of 0.81%.

When did iShares U.S. Medical Devices ETF's stock split? How did iShares U.S. Medical Devices ETF's stock split work?

iShares U.S. Medical Devices ETF's stock split on the morning of Monday, July 19th 2021. The 6-1 split was announced on Monday, July 19th 2021. The newly created shares were issued to shareholders after the market closes on Monday, July 19th 2021. An investor that had 100 shares of iShares U.S. Medical Devices ETF stock prior to the split would have 600 shares after the split.

What other stocks do shareholders of iShares U.S. Medical Devices ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares U.S. Medical Devices ETF investors own include NVIDIA (NVDA), PayPal (PYPL), Cisco Systems (CSCO), Visa (V), Verizon Communications (VZ), AbbVie (ABBV), salesforce.com (CRM), Walt Disney (DIS), Intel (INTC) and Home Depot (HD).

What is iShares U.S. Medical Devices ETF's stock symbol?

iShares U.S. Medical Devices ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IHI."

Who are iShares U.S. Medical Devices ETF's major shareholders?

iShares U.S. Medical Devices ETF's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Morgan Stanley (3.13%), LPL Financial LLC (2.23%), UBS Group AG (1.27%), Meitav Dash Investments Ltd. (1.00%), Royal Bank of Canada (0.86%) and Harel Insurance Investments & Financial Services Ltd. (0.62%).

Which institutional investors are selling iShares U.S. Medical Devices ETF stock?

IHI stock was sold by a variety of institutional investors in the last quarter, including Barclays PLC, Psagot Value Holdings Ltd., Banco de Sabadell S.A, Financial Advocates Investment Management, Intrua Financial LLC, UMA Financial Services Inc., and NorthRock Partners LLC.

Which institutional investors are buying iShares U.S. Medical Devices ETF stock?

IHI stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, LPL Financial LLC, UBS Group AG, Meitav Dash Investments Ltd., Royal Bank of Canada, Harel Insurance Investments & Financial Services Ltd., Fisher Asset Management LLC, and Advisor Group Holdings Inc..

How do I buy shares of iShares U.S. Medical Devices ETF?

Shares of IHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iShares U.S. Medical Devices ETF's stock price today?

One share of IHI stock can currently be purchased for approximately $61.87.

How much money does iShares U.S. Medical Devices ETF make?

iShares U.S. Medical Devices ETF has a market capitalization of $8.36 billion.


This page was last updated on 12/5/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.